CD47 Blockade as an Adjuvant Immunotherapy for Resectable Pancreatic Cancer

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
Alex D MichaelsTodd W Bauer

Abstract

Purpose: Patients with pancreatic ductal adenocarcinoma (PDAC) who undergo surgical resection and adjuvant chemotherapy have an expected survival of only 2 years due to disease recurrence, frequently in the liver. We investigated the role of liver macrophages in progression of PDAC micrometastases to identify adjuvant treatment strategies that could prolong survival.Experimental Design: A murine splenic injection model of hepatic micrometastatic PDAC was used with five patient-derived PDAC tumors. The impact of liver macrophages on tumor growth was assessed by (i) depleting mouse macrophages in nude mice with liposomal clodronate injection, and (ii) injecting tumor cells into nude versus NOD-scid-gamma mice. Immunohistochemistry and flow cytometry were used to measure CD47 ("don't eat me signal") expression on tumor cells and characterize macrophages in the tumor microenvironment. In vitro engulfment assays and mouse experiments were performed with CD47-blocking antibodies to assess macrophage engulfment of tumor cells, progression of micrometastases in the liver and mouse survival.Results:In vivo clodronate depletion experiments and NOD-scid-gamma mouse experiments demonstrated that liver macrophages suppress the progression o...Continue Reading

References

Sep 14, 1994·Journal of Immunological Methods·N Van Rooijen, A Sanders
Jul 1, 1993·Cancer Immunology, Immunotherapy : CII·G HeuffS Meyer
Feb 1, 1997·World Journal of Surgery·C SpertiS Pedrazzoli
Sep 24, 2004·International Journal of Cancer. Journal International Du Cancer·Maarten TimmersFilip Braet
Feb 1, 2006·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Vito Racanelli, Barbara Rehermann
Oct 5, 2007·Critical Reviews in Oncology/hematology·Paola AllavenaAlberto Mantovani
Mar 12, 2008·The Journal of Cell Biology·Richard K Tsai, Dennis E Discher
Jan 16, 2009·The New England Journal of Medicine·Isidro Sánchez-García
Mar 25, 2009·Nature Reviews. Cancer·Christoph A Klein
Sep 22, 2009·The Journal of Surgical Research·Hiroshi KuraharaSonshin Takao
Sep 2, 2010·The Journal of Experimental Medicine·Kodi S Ravichandran
Dec 14, 2011·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·David PáezHeinz-Josef Lenz
Jan 24, 2012·Cell·Andrew D RhimBen Z Stanger
Mar 28, 2012·Proceedings of the National Academy of Sciences of the United States of America·Stephen B WillinghamIrving L Weissman
Mar 8, 2013·Nature Medicine·Julio A Aguirre-GhisoMaria Soledad Sosa
May 22, 2013·Proceedings of the National Academy of Sciences of the United States of America·Diane TsengIrving L Weissman
Jan 17, 2014·The Journal of Clinical Investigation·Nuray GülMarjolein van Egmond
Feb 27, 2015·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Michele CioffiChristopher Heeschen
Sep 4, 2015·Cancer Metastasis Reviews·Isaiah J Fidler, Margaret L Kripke
Jan 14, 2016·Nature Reviews. Gastroenterology & Hepatology·Felix Heymann, Frank Tacke
Mar 26, 2016·Cell·Srinivas MalladiJoan Massagué
Apr 2, 2016·Proceedings of the National Academy of Sciences of the United States of America·Geoffrey Wayne KrampitzIrving L Weissman
Apr 19, 2016·Nature Cell Biology·Sebastian R NielsenMichael C Schmid
Jan 6, 2017·CA: a Cancer Journal for Clinicians·Rebecca L SiegelAhmedin Jemal

❮ Previous
Next ❯

Citations

Apr 2, 2019·Clinical and Translational Medicine·S K DanielV G Pillarisetty
Nov 7, 2019·Expert Review of Anticancer Therapy·Emmanouil TzatzarakisSebastian Schölch
Feb 23, 2020·Frontiers in Immunology·Wenting ZhangHua Jin
Jan 11, 2020·Frontiers in Immunology·Elena Martin-OrozcoMaria Ayala-San Nicolas
Sep 17, 2020·Advanced Healthcare Materials·Ying CaiPengcheng Zhang
Nov 26, 2020·Journal of Cancer Research and Clinical Oncology·Zelin HouHeguang Huang
Oct 31, 2018·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Samantha DrennanFrancesco Forconi
Jan 7, 2021·Cancer Metastasis Reviews·Khatora S OppermanAndrew C W Zannettino
Jun 12, 2020·Seminars in Cancer Biology·Aaron T CinerPnina Brodt
Nov 19, 2020·Journal of Cellular Physiology·Chaoyu WangYizhuo Zhang
Jan 11, 2021·Journal of Experimental & Clinical Cancer Research : CR·Bin WangXin Jiang
Jan 8, 2021·Journal of Translational Medicine·Violena Pietrobon, Francesco M Marincola
Oct 17, 2020·OncoTargets and Therapy·Quansheng LuGuan Jiang
Mar 17, 2021·International Immunopharmacology·Kanan PanchalAkash Chaurasiya
Apr 4, 2021·Biomedicines·Alberto Cruz-BermúdezMariano Provencio
May 11, 2021·World Journal of Clinical Cases·Jai Hoon YoonSung-Hoon Moon
May 28, 2021·EMBO Reports·Shannon M Kelley, Kodi S Ravichandran
Jul 2, 2021·Journal of Immunology Research·Mario Orozco-MoralesOscar Arrieta
Oct 31, 2020·Cancer Letters·Jian YangHanxiang Zhan
Jun 4, 2019·Pharmacology & Therapeutics·Meredith L Stone, Gregory L Beatty
Jan 4, 2022·Cancer Biology & Therapy·Moein Ala

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Genomics (Keystone)

Cancer genomics approaches employ high-throughput technologies to identify the complete catalog of somatic alterations that characterize the genome, transcriptome and epigenome of cohorts of tumor samples. Discover the latest research using such technologies in this feed.

Cancer Cell Invasion: Nanomedicine

Nanomedicine is a promising alternative for cancer detection and therapy that utilizes nanoparticles, such as liposomes. Nanoparticles can potentially target cancer cell invasion and metastasis. Discover the latest research on Cancer Cell Invasion: Nanomedicine here.